Portfolio Co Investors 2026 for Euclidean Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Euclidean Capital accounts for 17 tracked companies with verified cap-table data, 17 of which disclose round sizes totalling $2.4B. The median disclosed raise is $100M, and the largest is Redesign Health at $415M, ahead of ASAPP ($400M) and SetPoint Medical ($220M).
The names that recur most often on these co-invested cap tables are Euclidean Capital (17 companies), The Column Group (6 companies), Viking Global Investors (3 companies), Samsara BioCapital (2 companies), Vida Ventures (2 companies), Nextech Invest (2 companies). By latest disclosed round, the market skews Series A (6), Series C (5), Series B (2), Growth (1).
Companies tracked: 17
Disclosed funding total: $2.4B across 17 companies
Median disclosed raise: $100M
Largest raise: Redesign Health — $415M
Stage mix: Series A 6 · Series C 5 · Series B 2 · Growth 1
